These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 16038021)
21. A functional annotation of subproteomes in human plasma. Ping P; Vondriska TM; Creighton CJ; Gandhi TK; Yang Z; Menon R; Kwon MS; Cho SY; Drwal G; Kellmann M; Peri S; Suresh S; Gronborg M; Molina H; Chaerkady R; Rekha B; Shet AS; Gerszten RE; Wu H; Raftery M; Wasinger V; Schulz-Knappe P; Hanash SM; Paik YK; Hancock WS; States DJ; Omenn GS; Pandey A Proteomics; 2005 Aug; 5(13):3506-19. PubMed ID: 16104058 [TBL] [Abstract][Full Text] [Related]
22. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides. Merrell K; Thulin CD; Esplin MS; Graves SW Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037 [TBL] [Abstract][Full Text] [Related]
23. Centralized data analysis of a large interlaboratory proteomics project: a feasibility study. Beer I; Barnea E; Admon A Proteomics; 2005 Aug; 5(13):3491-6. PubMed ID: 16052626 [TBL] [Abstract][Full Text] [Related]
24. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins. Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629 [TBL] [Abstract][Full Text] [Related]
25. Human Plasma PeptideAtlas. Deutsch EW; Eng JK; Zhang H; King NL; Nesvizhskii AI; Lin B; Lee H; Yi EC; Ossola R; Aebersold R Proteomics; 2005 Aug; 5(13):3497-500. PubMed ID: 16052627 [TBL] [Abstract][Full Text] [Related]
26. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Hsieh SY; Chen RK; Pan YH; Lee HL Proteomics; 2006 May; 6(10):3189-98. PubMed ID: 16586434 [TBL] [Abstract][Full Text] [Related]
27. Biomarker discovery from body fluids using mass spectrometry. Villar-Garea A; Griese M; Imhof A J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359 [TBL] [Abstract][Full Text] [Related]
28. Global and targeted quantitative proteomics for biomarker discovery. Veenstra TD J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222 [TBL] [Abstract][Full Text] [Related]
29. Technologies and methods for sample pretreatment in efficient proteome and peptidome analysis. Jiang X; Ye M; Zou H Proteomics; 2008 Feb; 8(4):686-705. PubMed ID: 18210368 [TBL] [Abstract][Full Text] [Related]
30. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Tang HY; Ali-Khan N; Echan LA; Levenkova N; Rux JJ; Speicher DW Proteomics; 2005 Aug; 5(13):3329-42. PubMed ID: 16052622 [TBL] [Abstract][Full Text] [Related]
31. Collection and handling of blood specimens for peptidomics. Tammen H; Hess R Methods Mol Biol; 2011; 728():151-9. PubMed ID: 21468946 [TBL] [Abstract][Full Text] [Related]
32. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732 [TBL] [Abstract][Full Text] [Related]
34. Data management and functional annotation of the Korean reference plasma proteome. Jeong SK; Lee EY; Cho JY; Lee HJ; Jeong AS; Cho SY; Paik YK Proteomics; 2010 Mar; 10(6):1250-5. PubMed ID: 20175082 [TBL] [Abstract][Full Text] [Related]
35. Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry. Aresta A; Calvano CD; Palmisano F; Zambonin CG; Monaco A; Tommasi S; Pilato B; Paradiso A J Pharm Biomed Anal; 2008 Jan; 46(1):157-64. PubMed ID: 18035512 [TBL] [Abstract][Full Text] [Related]
36. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry. Ramström M; Bergquist J FEBS Lett; 2004 Jun; 567(1):92-5. PubMed ID: 15165899 [TBL] [Abstract][Full Text] [Related]
37. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. Ahmed FE J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839 [TBL] [Abstract][Full Text] [Related]
38. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Yang Z; Hancock WS; Chew TR; Bonilla L Proteomics; 2005 Aug; 5(13):3353-66. PubMed ID: 16052617 [TBL] [Abstract][Full Text] [Related]
39. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989 [TBL] [Abstract][Full Text] [Related]
40. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides. Penno MA; Ernst M; Hoffmann P Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]